Trusheim Mark R.; Aitken Murray L.; Berndt Ernst R. - In: Forum for Health Economics & Policy 13 (2010) 1, pp. 1-45
While much has been written about the distinctions between biologics and small molecules in terms of their scientific, manufacturing and regulatory experiences, relatively little has been published comparing their clinical and commercial experiences. Employing a data base encompassing all 96...